Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDK1 | P06493 | 12/20 | 1.00 |
| ▸ | CDK2 | P24941 | 8/20 | 1.00 |
| ▸ | JAK1 | P23458 | 8/20 | 0.69 |
| ▸ | TYK2 | P29597 | 8/20 | 0.69 |
| ▸ | JAK3 | P52333 | 6/20 | 0.69 |
| ▸ | JAK2 | O60674 | 5/20 | 0.69 |
| ▸ | CCNB2 | O95067 | 5/20 | 0.69 |
| ▸ | CCNB1 | P14635 | 5/20 | 0.69 |
| ▸ | CCNB3 | Q8WWL7 | 5/20 | 0.69 |
| ▸ | EIF2AK2 | P19525 | 2/20 | 0.69 |
| ▸ | PLK4 | O00444 | 1/20 | 0.69 |
| ▸ | STK25 | O00506 | 1/20 | 0.69 |
| ▸ | RIOK3 | O14730 | 1/20 | 0.69 |
| ▸ | AURKA | O14965 | 1/20 | 0.69 |
| ▸ | GAK | O14976 | 1/20 | 0.69 |
| ▸ | DCLK1 | O15075 | 1/20 | 0.69 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.69 |
| ▸ | DAPK3 | O43293 | 1/20 | 0.69 |
| ▸ | NUAK1 | O60285 | 1/20 | 0.69 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.69 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4163080 | 0.95 | CDK1 (0.90) | CDK1CDK2JAK1TYK2JAK3 | |
| SCHEMBL12893413 | 0.91 | CDK1 (0.83) | CDK1CDK2JAK1TYK2JAK3 | |
| SCHEMBL12755102 | 0.89 | CDK1 (0.80) | CDK1CDK2JAK1TYK2JAK3 | |
| SCHEMBL4159410 | 0.88 | CDK1 (1.00) | CDK1CDK2JAK1TYK2JAK3 | |
| SCHEMBL4157634 | 0.86 | CDK1 (0.80) | CDK1CDK2JAK1TYK2JAK3 | |
| SCHEMBL4156172 | 0.86 | CDK1 (1.00) | CDK1CDK2JAK1TYK2JAK3 | |
| SCHEMBL12755099 | 0.86 | CDK1 (0.76) | CDK1CDK2JAK1TYK2JAK3 | |
| SCHEMBL12880550 | 0.85 | CDK1 (0.78) | CDK1CDK2JAK1TYK2JAK3 | |
| SCHEMBL4151510 | 0.85 | CDK1 (0.84) | CDK1CDK2JAK1TYK2JAK3 | |
| SCHEMBL4151506 | 0.85 | CDK1 (0.84) | CDK1CDK2JAK1TYK2JAK3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8299082-B2 | 1,2,4-triazolylaminoaryl (heteroaryl) sulfonamide derivatives | JANSSEN PHARMACEUTICA, N.V. (BE) | 2012-10-30 | — | — | US | disclosed |
| EP-1797049-A4 | 1,2,4-TRIAZOLYLAMINOARYL (HETEROARYL) SULFONAMIDE DERIVATIVES | JANSSEN PHARMACEUTICA NV (BE) | 2009-06-17 | — | — | EP | disclosed |
| EP-1797049-A1 | 1,2,4-TRIAZOLYLAMINOARYL (HETEROARYL) SULFONAMIDE DERIVATIVES | JANSSEN PHARMACEUTICA N.V. (BE) | 2007-06-20 | — | — | EP | disclosed |
| US-20060173020-A1 | 1,2,4-Triazolylaminoaryl (heteroaryl) sulfonamide derivatives | JANSSEN PHARMACEUTICA N.V. (BE) | 2006-08-03 | — | — | US | disclosed |
| WO-2006042215-A1 | 1,2,4-TRIAZOLYLAMINOARYL (HETEROARYL) SULFONAMIDE DERIVATIVES | JANSSEN PHARMACEUTICA, N.V. (BE) | 2006-04-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060173020-A1 | 1,2,4-Triazolylaminoaryl (heteroaryl) sulfonamide derivatives | CCNI, CCNA2, CCNA1 | CDK1 42/4885CDK2 7/4885JAK1 1232/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.